secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rennova Health, Inc. (—)
CIK:        0000931059
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001493152-24-011342
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rennova Health reports expiration of ~403.8B shares of warrants, extends 101.35B Series B warrants to Dec 2025
--------------------------------------------------------------------------------

- Warrants to purchase ~403.8 billion shares (Series A, B, C) expired on March 21, 2024, reducing potential dilution.
- Series B warrants for 101.35 billion shares extended from March 21, 2024 to December 31, 2025, subject to exercise conditions.
- Exercise conditions require specified share volumes exercised by dates from April 2024 to August 2025; no cashless exercise counts.
- CEO Seamus Lagan stated the expiration significantly reduces potential dilution and the extension preserves capital access if conditions permit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/931059/000149315224011342/0001493152-24-011342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/931059/000149315224011342/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer